Projects per year
Personal profile
Education
- 2010-2013 Ph.D., Biomedical Electronics and Bioinformatics, National Taiwan University Hospital
- 1981-1997 M.D., Department of Medicine, Chang-Gung University
Experience
- 2023.02- Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- 2023.02- Professor, Professional Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University
- 2021.08- Director, Division of Thoracic Medicine, Department of Internal Medicine, Taipei Municipal Wanfang Hospital
- 2020.02-2023.01 Associate Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- 2020.02-2023.01 Associate Professor, Professional Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University
- 2019.08-2020.01 Assistant Professor, Professional Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University
- 2019.05-2019.07 Assistant Professor, Preparatory Office, Professional Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University
- 2014- Chief, Tuberculosis Center, Taipei Municipal Wanfang Hospital
- 2014.11 Attending Physician, Division of Pulmonary Medicine, Wanfang Hospital
- 2014.11-2020.01 Assistant Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- 2004-2013 Attending Physician, Taipei Tzu Chi Hospital
- 2003.07-2004.10 Attending Physician, Far Eastern Memorial Hospital
Awards
- 2019 Affiliated Hospital Research Project Award, Taipei Medical University
- 2014 Best reviewer of Pharmacoepidemiology and Drug Safety.
Research Interests
- Tuberculosis
- Chronic obstructive pulmonary disease
- Health Information Database
- Critical Care Medicine
Fingerprint
Dive into the research topics where Chih-hsin Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 5 Finished
-
Elucidating the Association of Toll-Like Receptor II Mediated Immune Cell Response and Susceptibility to Tuberculosises in Patients with Diabetes Mellitus
Lee, C.-H. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
分析結核病接觸者周邊血調節型T淋巴球與潛伏結核感染的關聯性-III
Lee, C.-H. (PI)
1/1/21 → 12/31/21
Project: B - Project of TMU › h - Higher Education Sprout Project
-
分析結核病接觸者周邊血調節型T淋巴球與潛伏結核感染的關聯性
Lee, C.-H. (PI)
1/1/20 → 12/1/20
Project: B - Project of TMU › h - Higher Education Sprout Project
-
分析結核病接觸者周邊血調節型T淋巴球與潛伏結核感染的關聯性
Lee, C.-H. (PI)
1/1/19 → 12/1/19
Project: A - Government Institution › d - Ministry of Education
-
穿戴式裝置於老人及高風險結核病病人偵測因藥物導致的QT間距延長之能力探討
Lee, C.-H. (PI)
1/1/19 → 12/31/19
Project: C - Project of Alliance › j - National Taipei University of Technology
-
The prognostic value of NT-proBNP in 28-day mortality and post-discharge survival in pneumonia: a retrospective cohort study from Taiwan
Nguyen, V. D., Lin, H. C., Lee, W. C., Ju, K. S., Dai, J. E., Hsieh, P. N., Chen, C. Y. & Lee, C. H., 2025, In: Expert Review of Respiratory Medicine. 19, 3, p. 257-267 11 p.Research output: Contribution to journal › Article › peer-review
-
Two-drug versus three-drug regimens for treating Mycobacterium avium complex infection: A systematic review and meta-analysis
Nguyen, V. D., Duong, H., Lee, M. C., Chen, J. H., Huang, W. C., Chen, H. E., Lin, J. C., Wang, J. Y. & Lee, C. H., May 2025, In: Journal of Infection and Public Health. 18, 5, 102711.Research output: Contribution to journal › Article › peer-review
Open Access -
Unveiling unique effector function-related bulk antibody profiles in long-term hemodialysis patients following COVID-19 mRNA booster vaccination
Chou, C. Y., Cheng, C. Y., Lee, C. H., Kuro-O, M., Chen, T. H., Wang, S. Y., Chuang, Y. K., Yang, Y. J., Lin, Y. H. & Tsai, I. L., Feb 2025, In: Journal of Microbiology, Immunology and Infection. 58, 1, p. 27-37 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19
Liu, W. D., Feng, P. H., Cheng, C. Y., Chou, C. L., Lee, C. H., Lu, M. C., Liu, P. Y., Lee, M. H., Liao, C. H., Chen, M. C., Chen, C. P., Hsu, S. F., Tzeng, Y. T., Lin, Y. C., Ou, T. Y., Qin, A., Tsai, C. Y., Shih, W. J., Lee, K. Y. & Sheng, W. H., 2024, (Accepted/In press) In: Infectious Diseases and Therapy. 13, 7, p. 1575-1588 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Clofazimine and QT prolongation in the treatment of rifampicin-resistant tuberculosis: Findings of aDSM in Taiwan
Lin, C. J., Chen, J. H., Chien, S. T., Huang, Y. W., Lin, C. B., Lee, J. J., Lee, C. H., Yu, M. C. & Chiang, C. Y., Oct 2024, In: Journal of Microbiology, Immunology and Infection. 57, 5, p. 791-800 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus)
Datasets
-
Additional file 3: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C.-M. (Contributor), Lee, C.-H. (Contributor), Lee, M.-C. (Contributor), Zhang, J.-F. (Contributor), Wang, J.-Y. (Contributor), Hu, R.-H. (Contributor) & Lee, P.-H. (Contributor), Unknown Publisher, Apr 10 2018
DOI: 10.6084/m9.figshare.6119174.v1, https://springernature.figshare.com/articles/Additional_file_3_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119174/1
Dataset
-
Additional file 5: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C.-M. (Contributor), Lee, C.-H. (Contributor), Lee, M.-C. (Contributor), Zhang, J.-F. (Contributor), Wang, J.-Y. (Contributor), Hu, R.-H. (Contributor) & Lee, P.-H. (Contributor), Unknown Publisher, Apr 10 2018
DOI: 10.6084/m9.figshare.6119204.v1, https://springernature.figshare.com/articles/Additional_file_5_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119204/1
Dataset
-
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C.-M. (Contributor), Lee, C.-H. (Contributor), Lee, M.-C. (Contributor), Zhang, J.-F. (Creator), Wang, J.-Y. (Contributor), Hu, R.-H. (Contributor) & Lee, P.-H. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4063952.v1, https://figshare.com/collections/Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/4063952/1
Dataset
-
Additional file 1: of Treatment delay and fatal outcomes of pulmonary tuberculosis in advanced age: a retrospective nationwide cohort study
Lee, C.-H. (Contributor), Wang, J.-Y. (Contributor), Lin, H.-C. (Contributor), Lin, P.-Y. (Contributor), Chang, J.-H. (Contributor), Suk, C.-W. (Contributor), Lee, L.-N. (Contributor), Lan, C.-C. (Contributor) & Bai, K.-J. (Contributor), Unknown Publisher, Jun 24 2017
DOI: 10.6084/m9.figshare.c.3810436_d1.v1, https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Treatment_delay_and_fatal_outcomes_of_pulmonary_tuberculosis_in_advanced_age_a_retrospective_nationwide_cohort_study/5143333/1
Dataset
-
Additional file 4: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C.-M. (Contributor), Lee, C.-H. (Contributor), Lee, M.-C. (Contributor), Zhang, J.-F. (Contributor), Wang, J.-Y. (Contributor), Hu, R.-H. (Contributor) & Lee, P.-H. (Contributor), Unknown Publisher, Apr 10 2018
DOI: 10.6084/m9.figshare.6119192.v1, https://springernature.figshare.com/articles/Additional_file_4_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119192/1
Dataset